Trials / Completed
CompletedNCT02592447
Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention
Preliminary Evaluation of an Internet-Assisted Cognitive Behavioral Intervention for Targeted Therapy Fatigue
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) with fatigued chronic myelogenous leukemia (CML) patients on tyrosine kinase inhibitors (TKIs) for feasibility, acceptability and potential efficacy relative to usual care only in a small-scale randomized controlled trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Therapy for Targeted Therapy-related Fatigue (TTF) | Cognitive Behavior Therapy for Targeted Therapy-related Fatigue (CBT-TTF) group will receive cognitive behavior therapy to help manage fatigue via FaceTime on an iPad, which will be provided to participants. Participants will meet with a trained therapist who will outline their therapy plan and will be taught how to use the iPad for upcoming therapy sessions. The sessions will initially be held weekly, but the therapist may schedule sessions at 1-, 2-, or 3-week intervals during the 18 week study period. The final session will be conducted either in-person at Moffitt or via FaceTime. |
| OTHER | Wait-List Control Condition (WLC) | Participants randomized to Wait-List Control Condition will continue to receive care under direction of their Moffitt Cancer Center (MCC) physician. Physicians will be informed by email of patients' participation on the basis of elevated fatigue and their randomization to WLC. Chart review and a patient self-report form will be used at baseline and follow-up assessments to determine what, if any, services or interventions participants received in the preceding 18 weeks that might address fatigue. |
Timeline
- Start date
- 2015-09-29
- Primary completion
- 2018-05-22
- Completion
- 2021-09-02
- First posted
- 2015-10-30
- Last updated
- 2021-11-16
- Results posted
- 2019-03-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02592447. Inclusion in this directory is not an endorsement.